Wall Street Analysts Think CorMedix (CRMD) Could Surge 117.77%: Read This Before Placing a Bet

CorMedix (CRMD) closed the last trading session at $5.74, gaining 45.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of$ 12.50 indicates an 117.8% upside potential. The mean estimate comprises four short-term price targets with a standard deviation of $4.51. While the lowest estimate of$ 9 indicates a 56.8% increase from the current price level, the most optimistic analyst expects ...